Cargando…

Impact of corticosteroids in hospitalised COVID-19 patients

BACKGROUND: Corticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study aimed to determine the association between corticosteroid use on mortal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Kam Sing, Narasimhan, Bharat, Difabrizio, Larry, Rogers, Linda, Bose, Sonali, Li, Li, Chen, Roger, Sheehan, Jacqueline, El-Halabi, Maan Ajwad, Sarosky, Kimberly, Wang, Zichen, Eisenberg, Elliot, Powell, Charles, Steiger, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023732/ https://www.ncbi.nlm.nih.gov/pubmed/33811098 http://dx.doi.org/10.1136/bmjresp-2020-000766

Ejemplares similares

Molecular epidemiological study of enterovirus D68 in hospitalised children in Hong Kong in 2014–2015 and their complete coding sequences
por: Wang, Haichao, et al.
Publicado: (2019)

Association of smoking status with outcomes in hospitalised patients with COVID-19
por: Adrish, Muhammad, et al.
Publicado: (2020)

Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014
por: Quan, T Phuong, et al.
Publicado: (2016)

Predictors of 30-day readmission following hospitalisation with community-acquired pneumonia
por: Chakrabarti, Biswajit, et al.
Publicado: (2021)

Shift work is associated with positive COVID-19 status in hospitalised patients
por: Maidstone, Robert, et al.
Publicado: (2021)

Clinical and financial burden of hospitalised community-acquired pneumonia in patients with selected underlying comorbidities in England
por: Campling, James, et al.
Publicado: (2020)

Hyperlipidaemia and mortality among patients hospitalised with pneumonia: retrospective cohort and propensity score matched study
por: Yousufuddin, Mohammed, et al.
Publicado: (2021)

A NOVEL EVIDENCE-BASED PREDICTOR TOOL FOR HOSPITALIZATION AND LENGTH OF STAY: INSIGHTS FROM PATIENTS WITH COVID-19 IN NEW YORK CITY
por: EL HALABI, MAAN, et al.
Publicado: (2021)

Clinical features of COVID-19 patients with rebound phenomenon after corticosteroid therapy
por: Murakami, Koji, et al.
Publicado: (2022)

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis
por: Dawson, Camilla, et al.
Publicado: (2023)

Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area
por: Sapey, Elizabeth, et al.
Publicado: (2020)

Association between influenza vaccination and hospitalisation or all-cause mortality in people with COVID-19: a retrospective cohort study
por: Wilcox, Christopher R, et al.
Publicado: (2021)

Impact of social deprivation on clinical outcomes of adults hospitalised with community-acquired pneumonia in England: a retrospective cohort study
por: Lawrence, Hannah, et al.
Publicado: (2022)

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
por: Berenguer, Juan, et al.
Publicado: (2021)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2021)

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
por: Nguyen-Van-Tam, J S, et al.
Publicado: (2010)

Risk factors of mortality among patients hospitalised with COVID-19 in a critical care or hospital care unit: analysis of the French national medicoadministrative database
por: Ouattara, Eric, et al.
Publicado: (2021)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
por: Stirrup, Oliver, et al.
Publicado: (2021)

Commentary on Eosinophilic Inflammation, Coronavirus Disease 2019, and Asthma: Are inhaled corticosteroids the missing link?
por: Ho, Kam Sing, et al.
Publicado: (2021)

Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study
por: Suehs, Carey Meredith, et al.
Publicado: (2020)

Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol
por: Binks, Michael J, et al.
Publicado: (2023)

Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2020)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2021)

(129)Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome
por: Kooner, Harkiran K, et al.
Publicado: (2022)

Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting β(2)-agonists in obstructive lung diseases: a population-based, observational study
por: Björnsdóttir, U S, et al.
Publicado: (2014)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia
por: Conway Morris, Andrew, et al.
Publicado: (2010)

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation
por: Wang, H, et al.
Publicado: (2009)

Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
por: Lauder, Sarah N, et al.
Publicado: (2011)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy
por: Spann, Kirsten M, et al.
Publicado: (2014)

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract
por: Moncayo-Nieto, Olga Lucia, et al.
Publicado: (2014)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
por: Dwyer, Richard, et al.
Publicado: (2014)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
por: Lim, W S, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i7kcur7b0i71aoedcrpgf5cvuh